SBRA has been the topic of a number of other research reports. ValuEngine lowered Zagg from a sell rating to a strong sell rating in a research report on Thursday, March 14th. TheStreet lowered Sabra Health Care REIT from a b- rating to a c+ rating in a research report on Monday, July 1st. Finally, Zacks Investment Research downgraded shares of Gold Resource from a hold rating to a sell rating in a research note on Friday, June 21st. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. Sabra Health Care REIT currently has an average rating of Hold and an average target price of $20.71.
Shares of NASDAQ SBRA opened at $20.49 on Thursday. The stock has a market capitalization of $3.68 billion, a price-to-earnings ratio of 8.95, a price-to-earnings-growth ratio of 11.35 and a beta of 0.89. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 1.06. Sabra Health Care REIT has a 52-week low of $15.70 and a 52-week high of $23.83. The firm has a 50 day moving average price of $19.69.
Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, May 8th. The real estate investment trust reported ($0.44) earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.94). Sabra Health Care REIT had a return on equity of 4.25% and a net margin of 23.38%. The company had revenue of $136.77 million for the quarter, compared to analysts’ expectations of $144.87 million. On average, analysts predict that Sabra Health Care REIT will post 1.9 EPS for the current fiscal year.
Several hedge funds have recently added to or reduced their stakes in the company. Centaurus Financial Inc. acquired a new stake in Sabra Health Care REIT during the first quarter worth approximately $34,000. Wealthcare Advisory Partners LLC boosted its position in Sabra Health Care REIT by 491.4% during the first quarter. Wealthcare Advisory Partners LLC now owns 2,419 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 2,010 shares during the last quarter. Bronfman E.L. Rothschild L.P. boosted its position in Sabra Health Care REIT by 913.7% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 3,112 shares of the real estate investment trust’s stock worth $51,000 after acquiring an additional 2,805 shares during the last quarter. Bessemer Group Inc. acquired a new stake in Sabra Health Care REIT during the fourth quarter worth approximately $55,000. Finally, Signaturefd LLC boosted its position in Sabra Health Care REIT by 43.7% during the first quarter. Signaturefd LLC now owns 3,924 shares of the real estate investment trust’s stock worth $76,000 after acquiring an additional 1,194 shares during the last quarter. Institutional investors and hedge funds own 89.40% of the company’s stock.
About Sabra Health Care REIT
As of December 31, 2018, Sabra's investment portfolio included 470 real estate properties held for investment (consisting of (i) 335 Skilled Nursing/Transitional Care facilities, (ii) 90 Senior Housing communities (?Senior Housing – Leased?), (iii) 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan and (iv) 18 other loans), nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.
Read More: Gap Down Stocks
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.